arrow
J

Jörg Hennenlotter

eberhard-karls-university
H指数:44
被引数:6,456

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder Cancer

《前瞻性随机UroFollow试验结果:比较标记物指导与膀胱镜检查为基础的监测在低/中危膀胱癌患者中的应用》

2025-05-070
PRE
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

基于TOFIMS质谱的免疫抗体优化肿瘤抗原鉴定

2023-11-177
OAAI
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
2022-06-0820
OAAI
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset
2022-01-117
OAAI
Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases
2019-07-0120
OAAI
Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer
2018-12-0363
OAAI